WHO ICTRP trial
A clinical study comparing two modalities for treating keloids: triamcinolone…
CTRI/2026/01/0101243 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2026/01/0101243 |
|---|---|
| Public title | A clinical study comparing two modalities for treating keloids: triamcinolone and hyaluronidase injection with and without platelet rich plasma therapy |
| Scientific title | Comparative study of intralesional triamcinolone acetonide injection and hyaluronidase with and without platelet rich plasma therapy in the treatment of keloids - NIL |
| Primary sponsor | Dr Baba saheb ambedkar hospital |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: L918- Other hypertrophic disorders of the skin |
| Interventions | Intervention1: intralesional triamcinolone acetonide and hyaluronidase and platelet rich plasma therapy: 4 doses of intralesional triamcinolone acetonide and hyaluronidase injection given at 3 weekly interval with platelet rich plasma… |
| Registration date | Jan 15, 2026 |
| Target size | 60 |
| Secondary IDs | Nil |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: